Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	1 Months Ended	8 Months Ended	9 Months Ended
	Feb. 02, 2021	Sep. 30, 2021	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 268,777	$ (132,830)	$ 115,869
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation, depletion, amortization and accretion	10,499	189,758	77,939
Deferred income taxes	54,322	(27,126)	7,254
Amortization of credit facility costs	0	0	381
Stock based compensation expense	935	2,126	3,519
Reorganization items, net	(354,279)	0	0
Bad debt	(210)	(5,303)	(106)
Gain on sale of assets and businesses	58	0	0
Gain on sale of equity securities	0	0	(3,611)
Unrealized gain on investment in equity securities	0	1,620	(908)
Other (gains) and losses, net	0	10,601	(37,148)
Other reconciling items, net	1,017	9,592	2,454
Changes in operating assets and liabilities:
Accounts receivable	3,602	(15,233)	(37,072)
Prepaid expenses	(340)	4,749	(279)
Inventory and other current assets	(221)	15,983	(8,641)
Accounts payable	(2,365)	4,842	(3,296)
Accrued expenses	23,489	(31,439)	(3,726)
Income taxes	340	10,676	7,200
Other, net	(241)	(1,190)	2,196
Net cash from operating activities	5,383	36,826	122,025
Cash flows from investing activities:
Payments for capital expenditures	(3,035)	(25,447)	(42,901)
Proceeds from sales of assets	775	58,006	46,414
Proceeds from sales of equity securities	0	0	13,366
Net cash from investing activities	(2,260)	32,559	16,879
Cash flows from financing activities:
Credit facility costs	(1,920)	(14)	0
Tax withholdings for vested restricted stock units	0	(1,485)	0
Net cash from financing activities	(1,920)	(1,499)	0
Effect of exchange rate changes on cash	311	0	0
Net change in cash, cash equivalents, and restricted cash	1,514	67,886	138,904
Cash, cash equivalents, and restricted cash at beginning of period	268,184	269,698	394,535
Cash, cash equivalents, and restricted cash at end of period	$ 269,698	$ 337,584	$ 533,439